TriNet, a leading global health research network optimizing clinical research to bring new therapies to market faster, announced global investment firm The Carlyle Group made a strategic growth investment and will acquire a majority stake in the company.
Genesis Drug Discovery & Development appointed Olesia Buiakova, M.D., Ph.D., as chief scientific officer.
BBK Worldwide – for 35 years on the crest of the wave with regard to the development and evolution of the patient recruitment industry – announced its new marketplace position as The Patient Experience Company.
Growth in fibromyalgia drug research over the past five years has made site selection a far less taxing prospect. There are now hundreds of sites capable of performing this research, and the challenge is to gather current feedback on them.
While acknowledging the many complexities of product development, sponsor teams should factor in these six guiding principles when planning programs for regulatory submission.
It’s a challenge to find and select the right consultants for a clinical study or drug trial.
Media Alert: Webinar on Improving Clinical Trial Performance – October 2015 WHAT: CRO Analytics will host an upcoming webinar in October, “QPIs: What They Are And How They Drive […]
Provides clients with broad range of standardized lab testing services and capabilities WILMINGTON, N.C. (April 20, 2015) – Pharmaceutical Product Development LLC (PPD) has opened a central laboratory in Shanghai, […]
-Technology and Industry Leader to Head eClinical Business Unit- NEWTOWN, PENNSYLVANIA, April 20, 2015 – BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced that Mukhtar […]
